CCR2 and non-small cell lung carcinoma: A slight, but significant increase in tumor size in the CCR2−/− mice compared to wild-type littermates was detected at the 44-week time point, which is consistent with the poorer survival observed in human NSCLC patients with low-CCL2 expression (48).